PerturbAI
An AI biotechnology company focused on single-cell perturbation data analysis, offering a large-scale genetic perturbation experiment data platform and computational analysis tools for functional genomics research.
Timeline (last 90 days)
GPT-Rosalind worked with PerturbAI and Scripps Research, with thousands of AI agents working in parallel to connect the gene expression results of millions of mouse brain cells with scientific literature.
OpenAI, PerturbAI and Scripps Research collaborated to orchestrate thousands of AI agents to analyze data from millions of brain cells in parallel and screen out research leads worth following up.
All Facts (2)
GPT-Rosalind worked with PerturbAI and Scripps Research, with thousands of AI agents working in parallel to connect the gene expression results of millions of mouse brain cells with scientific literature.
50%UnverifiedOpenAI, PerturbAI and Scripps Research collaborated to orchestrate thousands of AI agents to analyze data from millions of brain cells in parallel and screen out research leads worth following up.
50%